NeuroTherapia
Alzheimer's Disease | NeuroTherapia, Inc. | United States.
Launch date
Employees
Market cap
-
Enterprise valuation
€45—67m (Dealroom.co estimates Aug 2024.)
Gates Mills Ohio (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$1.7m | Seed | ||
N/A | N/A | Series A | |
$8.8m | Series A | ||
* | N/A | Grant | |
* | $12.3m | Series B | |
Total Funding | €21.6m |
Related Content
Recent News about NeuroTherapia
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.